These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4864194)

  • 21. Prevalence of secondary dapsone resistance in Nepal.
    Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB
    Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM; Ibanez MA
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of in vitro Fc receptor assay with in vivo mouse foot pad method.
    Jagannathan R; Patil D; Mahadevan PR
    Indian J Lepr; 1988 Oct; 60(4):517-25. PubMed ID: 3075631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
    [No Abstract]   [Full Text] [Related]  

  • 25. The first decade in experimental leprosy.
    Shepard CC
    Bull World Health Organ; 1971; 44(6):821-7. PubMed ID: 4950564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary sulphone resistance in leprosy (Report of a case).
    Lal S; Jaganath C; Garg BR; Paneerselvam R
    Lepr India; 1980 Apr; 52(2):299-301. PubMed ID: 7005542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary dapsone resistance in leprosy.
    Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
    Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
    Indian J Lepr; 2000; 72(4):437-42. PubMed ID: 11212477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary dapsone-resistant leprosy in San Francisco.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
    Hastings RC; Richard V; Christy SA; Morales MJ
    Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent chemotherapy of experimental leprosy in mice.
    Colston MJ; Hilson GR; Lancaster RD
    Am J Trop Med Hyg; 1980 Jan; 29(1):103-8. PubMed ID: 6153254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
    Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.
    Gelber RH; Siu P; Tsang M; Murray LP
    Antimicrob Agents Chemother; 1991 Apr; 35(4):760-3. PubMed ID: 1648889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
    Dhople AM
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo activities of ofloxacin against Mycobacterium leprae infection induced in mice.
    Saito H; Tomioka H; Nagashima K
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):560-2. PubMed ID: 3546546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary observation on the effect of thymic peptide in the experimental infection of mice with mycobacterium leprae].
    Wang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Jun; 7(3):227-8. PubMed ID: 2939979
    [No Abstract]   [Full Text] [Related]  

  • 39. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
    [No Abstract]   [Full Text] [Related]  

  • 40. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.